News | August 07, 2007

Angiomax Included in Updated AHA/ACC Guidelines

August, 8, 2007 - The Medicines Company announced that the new guidelines released yesterday by the American College of cardiology (ACC) and the American Heart Association (AHA) grant a Class I (level of evidence B) recommendation that Angiomax "should be administered" as one of the choices for anticoagulant therapy for patients with unstable angina (UA) and non-ST-elevated myocardial infarction (NSTEMI) who are selected to receive an invasive strategy.

Angiomax is used for patients undergoing percutaneous coronary intervention (PCI), is currently approved commonly referred to as angioplasty. The guidelines note that an invasive strategy should be considered for patients with high-risk characteristics. The guidelines state anticoagulant therapy should be given with antiplatelet therapy, such as aspirin, thienopyridines, and/or GP IIb/IIIa inhibitors. UA and NSTEMI are the most common forms of acute coronary syndromes.

"On the strength of the ACUITY trial results, Angiomax is included in U.S. ACS guidelines for the first time," said John Kelley, President and Chief Operating Officer of The Medicines Company "The clinical importance of the ACUITY data have supported publications in three leading, peer-reviewed medical journals and recommendations for Angiomax in the management of ACS both in the U.S. and Europe."

The Medicines Company also announced it submitted a supplemental new drug application (sNDA) to the FDA for Angiomax (bivalirudin), in support of a proposed new dosage for immediate treatment of patients with acute coronary syndromes (ACS).

For more information: www.themedicinescompany.com

Related Content

Stryker Sustainability Solutions, Angiodynamics Soft Vu Omni Flush Angiographic Catheters, recall
News | Angiographic Catheter| July 25, 2016
Stryker Sustainability Solutions (formerly Ascent Healthcare Solutions) is recalling Angiodynamics Soft Vu Omni Flush...
Cook Medical, expanded recall, October 2015, Beacon Tip Angiographic Catheters

Image courtesy of Cook Medical

News | Angiographic Catheter| October 14, 2015
On Oct. 7, 2015, Cook Medical initiated a voluntary recall for select sizes of Beacon Tip Angiographic Catheters. This...
Cook Medical, global recall, beacon tip angiographic catheters, FDA
News | Angiographic Catheter| August 11, 2015
On July 2, Cook Medical initiated a voluntary recall of 2,239 lots of beacon tip angiographic catheters. A total of 95,...
Technology | August 01, 2013
The Mikro-Cath disposable blood pressure catheter delivers accurate and reliable hemodynamic data from within the heart...
Surefire Medical Angiographic Catheters Interventional Rediology
Technology | October 15, 2012
Surefire Medical Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its line of...
Technology | August 08, 2012
Aug. 8, 2012 — Vascular Solutions Inc. launched the SuperCross FT, a new flexible-tip version of its line of SuperCross...
News | November 18, 2011
November 18, 2011 – The first comprehensive report to review timing of treatment for patients with blockages in more...
News | March 23, 2011
March 23, 2011 - Millar Instruments Inc. is issuing a worldwide recall of 1,080 units of its Human Use High Injection...
News | August 25, 2008
August 25, 2008 - Angioplasty catheter maker AngioScore Inc.
News | July 27, 2008
July 28, 2008 - OrbusNeich today added the Sapphire NC coronary dilatation non-compliant balloon catheter to its prod
Overlay Init